Efficacy of chloroquine and sulfadoxine/pyrimethamine mono- and combined therapy against falciparum malaria in Sudan

Eastern Mediterranean Health Journal

Volumn 13, Issue 1, 2007, Pages 25-34

  Elamin, Sakinaba B ^a   Malik, El F M ^a   Ahmed, El D S ^b   ElAbadi, E K ^a   Mohamad, T A ^a  

^a FEDERAL MINISTRY OF HEALTH   (Sudan)

^b UNIVERSITY OF JUBA   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FANSIDAR; ANTIMALARIAL AGENT; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MONOTHERAPY; NONHUMAN; SUDAN; AGE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; DRUG RESISTANCE; FEMALE; FEVER; INFANT; MALE; MULTICENTER STUDY; PARASITOLOGY; PATIENT SELECTION; PRACTICE GUIDELINE; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADULT; AGE FACTORS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PATIENT SELECTION; PRACTICE GUIDELINES; PYRIMETHAMINE; SUDAN; SULFADOXINE; TREATMENT OUTCOME;

EID: 34347354331     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Olliaro PL, Taylor WRJ. Review article antimalarial compound from bench to beside. Journal of experimental biology, 2003, 206:3753-9.
2. Bloland PB et al. Beyond chloroquine implication of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of infectious diseases, 1993, 167(4):932-7.
3. Nuwaha F. The challenge of chloroquine-resistant malaria in sub-Saharan Africa. Health policy and planning, 2001, 16(1):1-12.
4. Kouznetsov RL et al. Use of the in vitro microtechnique for the assessment of drug sensitivity of Plasmodium, falciparum in Sennar, Sudan. Bulletin of the World Health Organization, 1980, 58:785-9.
5. Altawil N, Akood N. Response of falciparum malaria to standard regimen of chloroquine in Khartoum Province, Sudan. East Africa medical journal, 1983, 60:663-8.
6. Ibrahim SM. In vitro sensitivity of Plasmodium falciparum to chloroquine in some areas in Sudan [MSc Thesis]. Khartoum, University of Khartoum, 1986.
7. Abdel-Hameed AA, El-Jak IE, Faragalla IA. Sentinel posts for monitoring antimalarial drugs efficacy against P. falciparum infections in Sudan. African journal of medicine and medical science, 2001, 30(suppl.):1-5.
8. Report of a WHO Study Group on the Implementation of the Global Plan of Action for Malaria Control 1993-2000. Geneva, World Health Organization, 1993 (WHO Technical Report Series, No. 839).
9. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva, World Health Organization, 2003 (WHO/HTM/RBM/2003.50).
10. Alessandro UDA, Butten H. History and importance of antimalarial drugs. Tropical medicine & international health, 2003, 6(1):845-8.
11. Goodman CA, Mills AJ. The evidence base on cost-effectiveness of malaria control measures in Africa. Health policy and planning, 1999, 14(4):301-2.
12. Stivanello E. Efficacy of chloroquine, sulphadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Kajo Keji county, Sudan. Tropical medicine & international health, 2004 9(9):975-80.
13. Anderson TJ et al. Molecular assessment of drug resistance in Plasmodium falciparum from Bahr El Gazal Province, Sudan. Tropical medicine & international health, 2003, 8:1068-73.
14. van den Broek IV et al. Chloroquine, sulfadoxine/pyrimethamine and amodiaquine efficacy for the treatment of uncomplicated falciparum malaria in Upper Nile, south Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2003, 97:229-35.
15. Schwobel B et al. Therapeutic efficacy of chloroquine plus sulphadoxine/ pyrimethamine compared with monotherapy with either chloroquine or sulphadoxine/pyrimethamine in uncomplicated Plasmodium falciparum malaria in Laos. Tropical medicine & international health, 2003, 8:19-24.
16. Shah I et al. Chloroquine resistance in Pakistan and the upsurge of falciparum malaria in Pakistani and Afghan refugee populations. Annals of tropical medicine and parasitology, 1997, 91(6):591-602.
17. Day PK, Marsh K. Naturally acquired immunity to Plasmodium faiciparum. Parasitology today, 1991, 7(3):68-71.
18. Talisuna AO et al. Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children. Tropical medicine and international health, 2004, 9(2):222-9.
19. Ronn AM et al. High level of resistance of Plasmodium falciparum sulphadoxine/pyrimethamine in children in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1996, 90(2):179-81.
20. Warsame M et al. Therapeutic efficacy of chloroquine and sulfadoxine/ pyrimethamine against P. falciparum infection in Somalia. Bulletin of the World Health Organization, 2002, 80 (9):704-8.
21. Rowland M et al. Resistance of falciparum malaria to chloroquine and sulfadoxine-pyrimethamine in Afghan refugee settlements in western Pakistan: surveys by the general health services using a simplified in vivo test. Tropical medicine & international health, 1997, 2(11):1049-56.
22. Basco LK, Tahar R, Ringwald P. Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites. Antimicrobial agents and chemotherapy, 1998, 42(7):1811-4.
23. Bousema JT et al. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malaria journal, 2004, 3:18.
24. Sokhna CS, Trape JF, Robert V. Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine. Parasite, 2001, 8(1):243-50.
25. Antimalarial drug combination therapy. Report of a WHO Technical Consultation. Geneva, World Health Organization, 2001:12.
26. White NJ et al. Averting a malaria disaster. Lancet, 1999, 353(9168):1965-7.